Drugs / Boesenbergia
last change May 2022 re-read 3 minutes ago

Boesenbergia

Developed for
COVID-19
Investigated by
Mahidol University · Ministry of Health, Thailand

Trials 1

20222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT05019326 Aug 2021 → May 2022 COVID-19 Mahidol University Unknown No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Boesenbergia ClinicalTrials.gov intervention name — accepted as the source's own label NCT05019326 ↗